Pharmaceutical Research And Manufacturers Of America Fnd Inc
- Assets
- $24.5m
- Revenue
- $4.2m
- Investments
- $0.0
- Employees
- 4
- Location
- Washington, DC
- Founding
- 11/1965
- Data as of
- 12/2023
- EIN
- 52-6063009
Organization Overview
Pharmaceutical Research And Manufacturers Of America Fnd Inc is located in Washington, DC. The organization was established in 1965. According to its NTEE Classification (E60) the organization is classified as: Health Support, under the broad grouping of Health Care and related organizations. As of 12/2023, Pharmaceutical Research And Manufacturers Of America Fnd Inc employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Pharmaceutical Research And Manufacturers Of America Fnd Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Pharmaceutical Research And Manufacturers Of America Fnd Inc generated $4.2m in total revenue. The organization has seen a slow decline revenue. Over the past 8 years, revenues have fallen by an average of (0.2%) each year. All expenses for the organization totaled $4.4m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Pharmaceutical Research And Manufacturers Of America Fnd Inc has awarded 35 individual grants totaling $951,691. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE O
Describe the Organization's Program Activity:
Part 3 - Line 4a
DRUG DISCOVERY - SUPPORTS EARLY CAREER RESEARCHERS WHOSE RESEARCH CAN HELP ACCELERATE BIOLOGICAL VALIDATION OF POTENTIAL DRUG TARGETS, SIGNALING PATHWAYS, OR MECHANISMS OF DISEASE.
VALUE ASSESSMENT-HEALTH OUTCOMES RESEARCH - SUPPORTS RESEARCHERS INVESTIGATING CHALLENGES IN EVALUATING THE DELIVERY, SAFETY, EFFECTIVENESS, AND VALUE OF HEALTH CARE INTERVENTIONS.
DRUG DELIVERY - SUPPORTS EARLY CAREER RESEARCHERS STUDYING WAYS TO OPTIMIZE DRUG COMPOSITION, DOSAGE, AND DELIVERY TO MAKE TREATMENTS SAFER, MORE EFFECTIVE, AND EASIER TO MANAGE FOR PATIENTS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Amy Miller President | Officer | 37.5 | $473,105 |
Emily Ortman Senior Director | 37.5 | $181,481 | |
Joanne Westphal Director | 37.5 | $171,183 | |
Andrew Plump MD PHD Chairman | OfficerTrustee | 1 | $0 |
Iris Loew-Friedrich MD Treasurer | OfficerTrustee | 1 | $0 |
George Addona PHD Director | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
O'connor Consulting Services Llc Accounting Services | 12/30/22 | $112,675 |
Reservoir Communications Group Llc Consulting | 12/30/22 | $120,000 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $3,576,216 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $3,576,216 |
| Total Program Service Revenue | $0 |
| Investment income | $496,762 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $171,752 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $4,244,730 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $206,000 |
| Grants and other assistance to domestic individuals. | $2,746,608 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $544,288 |
| Compensation of current officers, directors, key employees. | $167,024 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $334,773 |
| Pension plan accruals and contributions | $68,411 |
| Other employee benefits | $58,851 |
| Payroll taxes | $45,681 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $32,011 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $22,013 |
| Fees for services: Other | $163,297 |
| Advertising and promotion | $18,633 |
| Office expenses | $1,699 |
| Information technology | $32,243 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $29,969 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $23,590 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $5,454 |
| Insurance | $8,735 |
| All other expenses | $0 |
| Total functional expenses | $4,366,003 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,396,883 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $20,886 |
| Net Land, buildings, and equipment | $92,724 |
| Investments—publicly traded securities | $22,970,816 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $24,481,309 |
| Accounts payable and accrued expenses | $374,751 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $29,770 |
| Total liabilities | $404,521 |
| Net assets without donor restrictions | $24,076,788 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $24,481,309 |
Grants Awarded
Over the last fiscal year, Pharmaceutical Research And Manufacturers Of America Fnd Inc has awarded $201,000 in support to 9 organizations.
| Grant Recipient | Amount |
|---|---|
UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF PURPOSE: Digital Health Technology Planning grant | $25,000 |
NORTHWESTERN MEMORIAL FOUNDATION PURPOSE: Digital Health Technology Planning grant | $25,000 |
JOHNS HOPKINS UNIVERSITY PURPOSE: Digital Health Technology Planning grant | $25,000 |
THE UNIVERSITY OF TEXAS AT AUSTIN PURPOSE: Digital Health Technology Planning grant | $25,000 |
HONOR HEALTH RESEARCH INSTITUTE PURPOSE: Digital Health Technology Planning grant | $25,000 |
STATE UNIVERSITY OF IOWA PURPOSE: Digital Health Technology Planning grant | $25,000 |